Aldeyra Therapeutics, Inc.’s ALDX share price has surged by 23.94%, which has investors questioning if this is right time to sell.

Aldeyra Therapeutics shares fell 73% to $1.42 in the regular session after it reported a Food and Drug Administration complete response letter for reproxalap for treatment of dry eye disease. The ...

Wormhole (W) faces mixed technical signals as it nears a $137M unlock, with key resistance levels and trend momentum in focus ...

Acura ADX isn’t trying to be everything to everyone — it’s just really good at being exactly what a lot of people want right ...

The Competition Bureau pushed back on Google in its ongoing lawsuit over the tech giant's advertising practices in Canada, ...

Hedera faces bearish pressure as HBAR technicals warn of further downside amid "Liberation Day" uncertainty and weakening ...

Gabelli Dividend & Income Trust (GDV) announced a plan to spin-off of a new preferred-focused fund, Gabelli Preferred ...

Cardano faces strong bearish pressure with whale exodus and technical indicators pointing downward, though increased ...

Pi Network nears a new all-time low as bearish momentum grows, with investor uncertainty and outflows weighing heavily on its ...

The BMW X2 is among the most athletic in its subcompact class, but some competitors might prove to be more entrancing.

Charleston is full of people who want their constituents to believe they are there to do what is best for West Virginia. Luckily, a few of them are truly working ...